Vertex Pharmaceuticals, Inc (NASDAQ:VRTX) price on Thursday, July 03, rose 0.57% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $459.62.
A look at the stock’s price movement, the close in the last trading session was $457.03, moving within a range at $456.575 and $461.05. The beta value (5-Year monthly) was 0.418. Turning to its 52-week performance, $519.88 and $377.85 were the 52-week high and 52-week low respectively. Overall, VRTX moved 2.94% over the past month.
Vertex Pharmaceuticals, Inc’s market cap currently stands at around $118.03 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-05.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VRTX is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
16 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 5 analyst(s) rate the stock as a Hold, 11 recommend VRTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VRTX’s current price about 2.36% and 1.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.62, while 7-day volatility ratio is 1.85% and 2.02% in the 30-day chart. Further, Vertex Pharmaceuticals, Inc (VRTX) has a beta value of 0.44. Analysts have given the company’s stock an average 52-week price target of $458, forecast between a low of $420 and high of $545. Looking at the price targets, the low is 8.62% off current price level while to achieve the yearly target high, price needs to move -18.58%. Nonetheless, investors will most likely welcome a 0.35% jump to $458 which is the analysts’ median price.
If we refocus on Vertex Pharmaceuticals, Inc (NASDAQ:VRTX), historical trading data shows that trading volumes averaged 1.41 over the past 10 days and 1.72 million over the past 3 months. The company’s latest data on shares outstanding shows there are 256.97 million shares.
The 0.31% of Vertex Pharmaceuticals, Inc’s shares are in the hands of company insiders while institutional holders own 94.73% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.03 million on 2025-06-13, giving us a short ratio of 2.78. The data shows that as of 2025-06-13 short interest in Vertex Pharmaceuticals, Inc (VRTX) stood at 177.0 of shares outstanding, with shares short falling to 4.82 million registered in 2025-05-15. Current price change has pushed the stock -2.47% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VRTX stock continues to rise going into the next quarter.
